User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -14.00 -1.56% 886.00 870.00 890.00 895.00 875.00 895.00 74,149 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16.3 -9.7 -17.3 - 659

Maxcyte Share Discussion Threads

Showing 601 to 622 of 725 messages
Chat Pages: 29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
11/3/2021
13:49
I've just come across this, looks compelling. In for a few.
zubes
11/3/2021
12:03
Been buying a few more today.
someuwin
11/3/2021
08:20
If you consider the price went down its highly likely those prints were delayed sells but it doesn't matter as clearly the price moves to where the buys match - for a short period we've had more sellers than buyers...unsurprising after the run in the last 12 months and market conditions for growth generally. News on nasdaq listing in q2 I would think. I agree most buying is being done by US funds at this point.
nimbo1
10/3/2021
18:50
Yeh jt must be. Look at those delayed buys. Absolutely hoovered up. Shame I didn’t see these whilst playing the trade down as the us corrected.
2theduke
10/3/2021
18:20
Was that a 3 million buy? Reckon most of the sells are being scooped up by the US funds?
hj996
10/3/2021
16:44
Well I don't know if that was the bottom today. Anyway could not resist a final tranche. 3000 @ 8.4775, not showing so I expect to see it recorded tomorrow....as a sell!
assagai
09/3/2021
21:03
Updated note from Trinity This improving visibility prompts us to revisit our valuation methodology resulting in a substantial upgrade to £1bn (1217p/share) vs £310m (402p) before. hTTps://www.trinitydelta.org/wp-content/uploads/2021/02/MaxCyte-Update-210208.pdf
pob69
08/3/2021
14:37
Here is a reference to MXCT from today's article from River and Mercantile's Dan Hanbury, Head of Income and Smaller Companies (I hold) "....As we all know, pharmaceuticals companies have also been forced into the limelight like never before this year. However even pre-Covid, technology platforms like MaxCyte that supply Big Pharma were providing sustainable growth options to augment income funds, without the pricing and regulatory risk of Big Pharma themselves." hTTps://riverandmercantile.com/sustainable-dividend-income-in-the-uk/
pob69
07/3/2021
21:12
Entertaining video highlighting MXCT investment opportunity (I hold and as he suggests it is a little reminicent of BVXP which I also hold) hTTps://www.youtube.com/watch?v=sY4TtXq57As
pob69
05/3/2021
10:42
MXCT presenting at proactive next week: hTTps://event.webinarjam.com/register/945/5vv20b3vp?j=698606&sfmc_sub=207589499&l=86_HTML&u=38515100&mid=100009383&jb=80
homebrewruss
05/3/2021
09:37
Could easily slip to 760p where the 200d mva is. A great co but one has to see the valuation downward adjustments occurring globally in the biotech, life sciences area...
montynj
03/3/2021
10:52
New product 'VLX' being launched in 2021 (from 19 minutes) hTTps://wsw.com/webcast/cowen81/mxct/1973772 hTTps://twitter.com/pepersoons/status/1367049668660776960
homebrewruss
03/3/2021
07:18
its on there now hTTps://maxcyte.com/corporate-presentations/
nimbo1
02/3/2021
10:17
Don't see yesterday's presentations yet. Thought it was going on the website? Maybe too soon...
assagai
27/2/2021
10:00
As a rule of thumb decent hedge funds only buy things like maxcyte if they think they can double their money. (They are not always right of course!) So d1 in at 7 means they expect 14 within 24 months and maybe more. Very crude but may as well keep it simple. I’m happy to ride out volatility too - it’s the only way to make it big and this should become a long term high growth compounding champion.
nimbo1
26/2/2021
23:31
Interesting today, the long overdue retrace was very quickly turned back on itself. So many other investments (hydrogen sector etc, that have had meteoric rises) have become very volatile ,with significant pull backs. After 500 % gain over the last year this seems very solid. As nimbo has flagged it seems quite a few shares have passed from satisfied hands to enthusiastic new ones. In today's climate the prospect of a share doubling in value is hard to resist, so let's ignore the gain to date and look upon this as a new investment we would like to see double, or maybe even better over the next year. If the potential for cash generation is even partially realised would it not be unreasonable to be expecting dividends in the future. On £20 plus a five % yield would be great but on an average of maybe £3 or £4 , the returns would be spectacular! So happy to break my golden rule and not take any profits,...at all. Warren Buffet isn't called the sage for nothing.
assagai
26/2/2021
15:23
Nope. Very long :)
nimbo1
26/2/2021
13:26
its good to have a fall, much needed consolidation going on - given all the large buys over the past 5 days (showing great institutional demand) will be interesting to see where it finds its level in the tricky market!
nimbo1
24/2/2021
14:29
Positive article with comments from James Brady Maxctye Vice President, Technical Applications and Customer Support hTTps://biobuzz.io/cell-and-gene-therapys-future-a-complex-mix-of-promise-and-pitfalls/
pob69
23/2/2021
07:47
Fingersxxxxd
assagai
23/2/2021
07:39
As these conference presentations are advertised as Corporate (rather than Clinical), I'm hoping they will coincide with the formal start of the Nasdaq application process.
someuwin
23/2/2021
07:33
https://www.google.com/url?rct=j&sa=t&url=https://www.fox8jobs.com/jobs/electromechanical-assembler-gaithersburg-maryland/234931826-2/&ct=ga&cd=CAEYACoUMTE4Mzg5NDY2NjkwNDUxMDUzODcyHDY0NjJhNDU2NjA4NmZhYTA6Y28udWs6ZW46R0I&usg=AFQjCNFumR_rVz67yC6sVyL7btDADfAy_Q
assagai
Chat Pages: 29  28  27  26  25  24  23  22  21  20  19  18  Older
ADVFN Advertorial
Your Recent History
LSE
MXCT
Maxcyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 13:11:08